Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027556
Filing Date
2021-05-13
Accepted
2021-05-13 16:15:48
Documents
53
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20210331.htm 10-Q 1496100
2 EX-31.1 achv-ex311_11.htm EX-31.1 9066
3 EX-32.1 achv-ex321_9.htm EX-32.1 4874
  Complete submission text file 0001564590-21-027556.txt   5368966

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT achv-20210331.xml EX-101.INS 1005376
5 XBRL TAXONOMY EXTENSION SCHEMA achv-20210331.xsd EX-101.SCH 50939
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20210331_cal.xml EX-101.CAL 38291
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20210331_def.xml EX-101.DEF 200846
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20210331_lab.xml EX-101.LAB 375286
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20210331_pre.xml EX-101.PRE 291261
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 21919832
SIC: 2835 In Vitro & In Vivo Diagnostic Substances